Glimter PM 1mg/500mg/7.5mg Tablet SR
Marketer
Bluewaterresearch
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (7.5mg)
Overview Glimter PM 1mg/500mg/7.5mg Tablet SR
Diabex Trio 1mg/500mg/7.5mg Extended-Release Tablets combine medications to manage blood glucose. This regimen, used alongside diet and exercise, enhances glycemic control in adult type 2 diabetics. It facilitates improved insulin use, thus reducing blood sugar. Adhere strictly to your physician's prescribed dosage and frequency for Diabex Trio. Take it with food to prevent digestive discomfort. If a dose is missed, take it promptly unless the next dose is imminent; then, skip the missed dose. Never double the dose; overdose risks hypoglycemia. Concurrent use with other antidiabetic drugs, alcohol, or skipped meals may trigger hypoglycemia. Regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or nursing individuals must seek medical counsel before use. Kidney function tests will be assessed before treatment begins. Limit alcohol consumption as it may amplify side effects.
Uses of Glimter PM 1mg/500mg/7.5mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimter PM 1mg/500mg/7.5mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimter PM 1mg/500mg/7.5mg Tablet SR whole; avoid chewing, crushing, or fracturing. Administer this medication with a meal.
Common Side effects of Glimter PM 1mg/500mg/7.5mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimter PM 1mg/500mg/7.5mg Tablet SR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimter PM 1mg/500mg/7.5mg Tablet SR whole; do not chew, crush, or divide it. Administer this medicine with a meal.
How Glimter PM 1mg/500mg/7.5mg Tablet SR works:
Glimter PM 1mg/500mg/7.5mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach enhances blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimter PM 1mg/500mg/7.5mg SR tablets with alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimter PM 1mg/500mg/7.5mg Extended-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against the risks before recommending this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimter PM 1mg/500mg/7.5mg tablet is likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when prescribing Glimter PM 1mg/500mg/7.5mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician. For patients exhibiting severe kidney disease, Glimter PM 1mg/500mg/7.5mg SR tablets are contraindicated. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimter PM 1mg/500mg/7.5mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimter PM 1mg/500mg/7.5mg Tablet SR :
Should you forget a dose of Glimter PM 1mg/500mg/7.5mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimter PM 1mg/500mg/7.5mg Tablet SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Category | Medication for diabetes |
3,018 People bought this recently